Investigating a protein's role in platelet function and blood clotting
ERO1 alpha in platelet activity and thrombosis
This study is looking at a protein called Ero1α to see how it influences platelets, which help your blood clot, and it aims to find new ways to treat issues with bleeding or blood clots, making sure we can prevent clots without causing too much bleeding.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10621694 on NIH RePORTER |
What this research studies
This research explores how a specific protein, Ero1α, affects the activity of platelets, which are crucial for blood clotting. By studying both animal models and biochemical methods, the researchers aim to understand how inhibiting Ero1α can alter platelet function and potentially lead to new treatments for conditions related to excessive bleeding or thrombosis. The project focuses on the balance between preventing blood clots and avoiding major bleeding risks associated with current antiplatelet therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions that predispose them to abnormal blood clotting or those who have experienced complications from existing antiplatelet medications.
Not a fit: Patients who do not have issues related to blood clotting or bleeding disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective antithrombotic therapies for patients at risk of thrombosis.
How similar studies have performed: Other research has shown promise in targeting similar pathways for improving antithrombotic therapies, suggesting that this approach could yield significant advancements.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Cho, Jaehyung — Washington University
- Study coordinator: Cho, Jaehyung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.